SARS Cov-2 Vaccines and Vaccination Strategies | ||
| Microbes and Infectious Diseases | ||
| Article 2, Volume 3, Issue 1, February 2022, Pages 3-12 PDF (316.16 K) | ||
| Document Type: Review Article | ||
| DOI: 10.21608/mid.2021.207742 | ||
| Authors | ||
| Nihala Naseefa C H* ; Sheeba P | ||
| Department of Zoology, Vimala College (Autonomous), Thrissur, Kerala, India | ||
| Abstract | ||
| A rapid change has been undergone in the current pandemic and many countries are being exposed to the third wave of covid-19. The tireless work for the discovery of vaccine had begun by the time the disease occupied a major part of the globe. This is mainly due to the efficacy of vaccines in preventing diseases and it is one of the cost effective strategies adopted for the prevention of many diseases. Currently a lot of countries have come forth with suitable vaccines to tackle the SARS CoV-2 to some extent. This paper incorporates details about vaccination and the common vaccines in use against covid-19. Based on the evidences available, keen observations and studies carried out on the previously emerged SARS and MERS, the vaccine against SARS CoV-2 was developed, however the primary focus depend on the spike protein which was considered as a target for the development of suitable immunotherapies and thereby played a potential role in the vaccine development process. Vaccination is the most significant strategy to stop the pandemic and the efficacy of SARS-CoV-2 vaccines provides a genuine gauge of hope for future. | ||
| Keywords | ||
| Vaccines; Antigen; Antibody; Spike protein | ||
|
Statistics Article View: 404 PDF Download: 337 |
||
